Alterations of Oxidative Phosphorylation Complexes in Papillary Thyroid Carcinoma

The papillary thyroid carcinoma (PTC) is the most common malignant tumor of the thyroid gland, with disruptive mutations in mitochondrial complex I subunits reported at very low frequency. Furthermore, metabolic diversity of PTC has been postulated owing to variable messenger RNA (mRNA) expression o...

Full description

Bibliographic Details
Main Authors: Franz A. Zimmermann, Daniel Neureiter, Wolfgang Sperl, Johannes A. Mayr, Barbara Kofler
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:Cells
Subjects:
Online Access:http://www.mdpi.com/2073-4409/7/5/40
_version_ 1827886480660365312
author Franz A. Zimmermann
Daniel Neureiter
Wolfgang Sperl
Johannes A. Mayr
Barbara Kofler
author_facet Franz A. Zimmermann
Daniel Neureiter
Wolfgang Sperl
Johannes A. Mayr
Barbara Kofler
author_sort Franz A. Zimmermann
collection DOAJ
description The papillary thyroid carcinoma (PTC) is the most common malignant tumor of the thyroid gland, with disruptive mutations in mitochondrial complex I subunits reported at very low frequency. Furthermore, metabolic diversity of PTC has been postulated owing to variable messenger RNA (mRNA) expression of genes encoding subunits of the oxidative phosphorylation (OXHPOS) complexes. The aim of the present study was to evaluate the metabolic diversity of the OXPHOS system at the protein level by using immunohistochemical staining. Analysis of 18 human PTCs revealed elevated mitochondrial biogenesis but significantly lower levels of OXPHOS complex I in the tumor tissue (p < 0.0001) compared to the adjacent normal tissue. In contrast, OXPHOS complexes II–V were increased in the majority of PTCs. In three PTCs, we found pathologic mutations within mitochondrially encoded complex I subunits. Our data indicate that PTCs are characterized by an oncocytic metabolic signature that is in low complex I is combined with elevated mitochondrial mass and high complex II–V levels, which might be an important factor for tumor formation.
first_indexed 2024-03-12T20:04:06Z
format Article
id doaj.art-c18a86e3f44f493c83bbea0490add880
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T20:04:06Z
publishDate 2018-05-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-c18a86e3f44f493c83bbea0490add8802023-08-02T02:14:53ZengMDPI AGCells2073-44092018-05-01754010.3390/cells7050040cells7050040Alterations of Oxidative Phosphorylation Complexes in Papillary Thyroid CarcinomaFranz A. Zimmermann0Daniel Neureiter1Wolfgang Sperl2Johannes A. Mayr3Barbara Kofler4Research Program for Receptor Biochemistry and Tumor Metabolism, University Hospital Salzburg, Paracelsus Medical University, Salzburg 5020, AustriaDepartment of Pathology, University Hospital Salzburg, Paracelsus Medical University, Salzburg 5020, AustriaDepartment of Pediatrics, University Hospital Salzburg, Paracelsus Medical University, Salzburg 5020, AustriaDepartment of Pediatrics, University Hospital Salzburg, Paracelsus Medical University, Salzburg 5020, AustriaResearch Program for Receptor Biochemistry and Tumor Metabolism, University Hospital Salzburg, Paracelsus Medical University, Salzburg 5020, AustriaThe papillary thyroid carcinoma (PTC) is the most common malignant tumor of the thyroid gland, with disruptive mutations in mitochondrial complex I subunits reported at very low frequency. Furthermore, metabolic diversity of PTC has been postulated owing to variable messenger RNA (mRNA) expression of genes encoding subunits of the oxidative phosphorylation (OXHPOS) complexes. The aim of the present study was to evaluate the metabolic diversity of the OXPHOS system at the protein level by using immunohistochemical staining. Analysis of 18 human PTCs revealed elevated mitochondrial biogenesis but significantly lower levels of OXPHOS complex I in the tumor tissue (p < 0.0001) compared to the adjacent normal tissue. In contrast, OXPHOS complexes II–V were increased in the majority of PTCs. In three PTCs, we found pathologic mutations within mitochondrially encoded complex I subunits. Our data indicate that PTCs are characterized by an oncocytic metabolic signature that is in low complex I is combined with elevated mitochondrial mass and high complex II–V levels, which might be an important factor for tumor formation.http://www.mdpi.com/2073-4409/7/5/40papillary thyroid carcinomamitochondriarespiratory chain complex I
spellingShingle Franz A. Zimmermann
Daniel Neureiter
Wolfgang Sperl
Johannes A. Mayr
Barbara Kofler
Alterations of Oxidative Phosphorylation Complexes in Papillary Thyroid Carcinoma
Cells
papillary thyroid carcinoma
mitochondria
respiratory chain complex I
title Alterations of Oxidative Phosphorylation Complexes in Papillary Thyroid Carcinoma
title_full Alterations of Oxidative Phosphorylation Complexes in Papillary Thyroid Carcinoma
title_fullStr Alterations of Oxidative Phosphorylation Complexes in Papillary Thyroid Carcinoma
title_full_unstemmed Alterations of Oxidative Phosphorylation Complexes in Papillary Thyroid Carcinoma
title_short Alterations of Oxidative Phosphorylation Complexes in Papillary Thyroid Carcinoma
title_sort alterations of oxidative phosphorylation complexes in papillary thyroid carcinoma
topic papillary thyroid carcinoma
mitochondria
respiratory chain complex I
url http://www.mdpi.com/2073-4409/7/5/40
work_keys_str_mv AT franzazimmermann alterationsofoxidativephosphorylationcomplexesinpapillarythyroidcarcinoma
AT danielneureiter alterationsofoxidativephosphorylationcomplexesinpapillarythyroidcarcinoma
AT wolfgangsperl alterationsofoxidativephosphorylationcomplexesinpapillarythyroidcarcinoma
AT johannesamayr alterationsofoxidativephosphorylationcomplexesinpapillarythyroidcarcinoma
AT barbarakofler alterationsofoxidativephosphorylationcomplexesinpapillarythyroidcarcinoma